Detalhe da pesquisa
1.
Bevacizumab as adjuvant treatment of colon cancer: updated results from the S-AVANT phase III study by the GERCOR Group.
Ann Oncol
; 31(2): 246-256, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31959341